Aptose Biosciences Inc. (15)

Browse by Contract Category

Contracts

Employment Agreement dated June 3, 2019 between Aptose Biosciences Inc. and Philippe Ledru (Filed With SEC on April 11, 2022)
Description of Securities (Filed With SEC on March 22, 2022)
Exclusive License Agreement, dated November 4, 2021, by and between Hanmi Pharmaceutical Co. Ltd. and Aptose Biosciences Inc (Filed With SEC on November 4, 2021)
Underwriting Agreement, dated July 15, 2020, between Aptose Biosciences Inc. and Piper Sandler & Co (Filed With SEC on July 16, 2020)
Consulting Agreement dated March 26, 2021 between Aptose Biosciences Inc. and Gregory K. Chow (Filed With SEC on May 4, 2021)
Description of Securities (Filed With SEC on March 23, 2021)
Equity Distribution Agreement, dated May 5, 2020, among Aptose Biosciences Inc., Piper Sandler & Co. and Canaccord Genuity LLC (Filed With SEC on May 5, 2020)
Description of Securities (Filed With SEC on March 10, 2020)
Form of Executive Employment Agreement, dated December 4, 2019, between the Company and Dr. Rafael Bejar (Filed With SEC on March 10, 2020)
Underwriting Agreement, dated December 16, 2019 between Aptose Biosciences Inc. and Piper Jaffray & Co (Filed With SEC on December 17, 2019)
Form of Executive Employment Agreement, dated June 3, 2019, between the Company and Dr. Jotin Marango (Filed With SEC on August 6, 2019)
Underwriting Agreement, dated May 30, 2019 among Aptose Biosciences Inc., RBC Capital Markets, LLC and Canaccord Genuity LLC (Filed With SEC on May 30, 2019)
Equity Distribution Agreement, dated May 24, 2019, among Aptose Biosciences Inc., Piper Jaffray & Co. and Canaccord Genuity LLC (Filed With SEC on May 24, 2019)
Form of Common Share Purchase Agreement dated May 7, 2019 by and between the Company and Aspire Capital Fund, LLC (Filed With SEC on May 7, 2019)
Form of Registration Rights Agreement dated May 7, 2019 by and between the Company and Aspire Capital Fund, LLC (Filed With SEC on May 7, 2019)